FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)

View source ↗

Summary

The FDA has approved a supplemental application for RAMIPRIL, allowing Chartwell RX, LLC to market a RAMIPRIL generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Post-myocardial Infarction

Drugs mentioned

• Ramipril (ramipril)

Snippet

SUPPL AP for RAMIPRIL (RAMIPRIL)